Evidence Level
Moderate
5 Clinical Trials
5 Documented Benefits
3/5 Evidence Score

Chromium is an essential trace mineral that plays a key role in regulating blood sugar by enhancing the effects of insulin, making it important for carbohydrate and fat metabolism. It is naturally found in small amounts in foods such as whole grains, broccoli, green beans, meat, poultry, nuts, and eggs. However, dietary absorption can vary, so supplements are often used to help maintain optimal levels. Common supplemental forms include chromium picolinate, chromium polynicotinate, and chromium chloride, with chromium picolinate being the most widely used in blood sugar support formulas.

Studied Dose 25–35 mcg/day (AI); blood sugar: 200–1,000 mcg/day chromium picolinate; insulin resistance studies use 400–1,000 mcg/day
Active Compound Chromium Picolinate / Chromium Polynicotinate
Deficiency information View details

Chromium's status as an essential nutrient is debated, and isolated dietary deficiency has never been definitively documented in healthy people. The few documented cases were patients on long-term TPN who developed insulin resistance reversed by chromium supplementation. Chromium is sold heavily as a 'blood sugar' supplement, but evidence for benefit in non-deficient people is weak.

Common symptoms

  • Documented chromium deficiency in humans is extremely rare and limited to TPN cases
  • Insulin resistance, impaired glucose tolerance
  • Unexplained weight loss
  • Confusion or impaired cognition
  • Peripheral neuropathy
  • Note: blood sugar issues in the general population almost always have causes other than chromium status

At-risk groups

  • People on long-term parenteral nutrition without chromium (only documented cases)
  • Note: insulin resistance, prediabetes, and type 2 diabetes are NOT chromium deficiency states
  • There are no validated lab tests reliably indicating chromium deficiency in the general population
When to see a doctor: If you have blood sugar concerns, insulin resistance, or diabetes, the evidence-based interventions are diet, exercise, weight management, and (when needed) metformin or other prescribed medications — NOT chromium supplements. While chromium picolinate is widely sold for blood sugar, meta-analyses show minimal-to-no clinically meaningful benefit for type 2 diabetes in non-deficient individuals. If you have actual symptoms of insulin resistance, see a doctor for proper evaluation.

Benefits

Blood Sugar Regulation

Chromium enhances insulin sensitivity, which may help improve blood sugar control. Some studies suggest it can benefit people with type 2 diabetes or insulin resistance, though results are mixed.

Metabolism Support

It aids in the metabolism of carbohydrates, fats, and proteins by supporting insulin function, potentially improving energy utilization.

Weight Management

Limited evidence suggests chromium (often as chromium picolinate) may reduce appetite or body fat in some individuals, but effects are minimal and not consistent across studies.

Cholesterol Levels

Some research indicates chromium may lower LDL ("bad") cholesterol and increase HDL ("good") cholesterol, potentially supporting heart health, though more studies are needed.

Polycystic Ovary Syndrome (PCOS)

Chromium supplementation may improve insulin sensitivity and hormonal balance in women with PCOS, but evidence is preliminary.

Mechanism of action

1

Insulin Sensitization

Chromium enhances insulin signaling by interacting with the insulin receptor and increasing glucose transporter (GLUT4) translocation to cell membranes, improving glucose uptake in cells.

2

Metabolic Regulation

It acts as a cofactor in the chromodulin complex, amplifying insulin’s effects on carbohydrate, fat, and protein metabolism.

3

Lipid Metabolism

Chromium may influence lipid profiles by modulating enzymes like HMG-CoA reductase, potentially lowering LDL cholesterol and raising HDL cholesterol.

Clinical trials

1
Chromium Picolinate and Cardiometabolic Biomarkers in T2DM — Clinical Trial

Randomized controlled trial of chromium picolinate (200 µg/day) vs placebo in 52 T2DM patients over 12 weeks. Outcomes: fasting glucose, HbA1c, lipid profile, insulin resistance. (Clin Nutr Res)

52 T2DM patients. 12-week intervention.

Chromium picolinate produced modest but statistically significant improvements in fasting glucose, HbA1c, and lipid markers vs placebo in T2DM patients. Effect sizes small. Adjunctive role rather than primary therapy.

2
Chromium-Enriched Yeast in Insulin-Treated T2DM — Clinical Trial

Randomized controlled trial of chromium-enriched yeast (400 µg/day chromium) vs placebo in 36 insulin-treated T2DM patients over 12 weeks. Outcomes: fasting plasma glucose, HbA1c, insulin requirements, lipid profile.

36 insulin-treated T2DM patients.

Chromium-enriched yeast significantly reduced fasting glucose and HbA1c vs placebo. Allowed modest reductions in insulin requirements in some patients. Suggests chromium-yeast (organic chromium form) may be preferable to picolinate for some patients.

3
Chromium and Cardiometabolic Risk — Dose-Response Evidence Synthesis

Pooled analysis (PROSPERO) of 23 clinical trials through examining chromium supplementation effects on cardiometabolic outcomes (glucose, HbA1c, lipids, BP) with dose-response analysis. (Liu et al. 2023, JACC Adv)

Pooled across 23 clinical trials.

In T2DM patients, chromium doses ≥400 µg/day significantly reduced fasting plasma glucose (WMD: -0.67 mmol/L) and HbA1c. Lower doses showed minimal effects. In non-diabetic populations, effects were not significant. Suggests chromium is most useful in diabetic populations at higher-end dosing.

4
Chromium and Blood Pressure — Evidence Synthesis

Evidence review and pooled analysis of 11 clinical trials through assessing chromium supplementation effects on systolic and diastolic blood pressure. (Eur J Clin Nutr)

Pooled across 11 clinical trials.

No significant overall effect of chromium supplementation on systolic or diastolic BP. Subgroup analyses suggested modest effects in T2DM populations but not in healthy or hypertensive non-diabetic subjects. Negative finding — chromium should not be promoted for BP reduction.

5
Chromium and Cognition in Older Adults with Memory Decline — Clinical Trial

Randomized controlled trial in 26 older adults (mean age ~65) with early memory decline receiving chromium picolinate (1,000 µg/day) vs placebo for 12 weeks. fMRI imaging and cognitive testing. (Nutr Neurosci)

26 older adults with early memory decline. 12-week intervention.

Chromium picolinate group showed improved cognitive-cerebral function on fMRI activation patterns and modest cognitive test improvements vs placebo. Note: small sample, single trial; not yet replicated. Theoretical mechanism via insulin signaling effects on cerebral glucose metabolism.

Side effects and drug interactions

Common Potential side effects

Gastrointestinal Issues: Common side effects include nausea, stomach irritation, vomiting, or diarrhea, especially at higher doses (e.g., above 1,000 mcg/day) or when taken on an empty stomach. Some users report abdominal pain or bloating.
Headaches and Dizziness: Mild headaches or dizziness may occur, potentially due to chromium’s effects on blood sugar or blood pressure, particularly in sensitive individuals.
Allergic Reactions: Rare allergic reactions, such as skin rash, itching, or swelling, may occur, particularly with chromium picolinate. Severe allergic reactions (e.g., anaphylaxis) are extremely rare but possible.
Blood Sugar Changes: Chromium may lower blood sugar, which can cause hypoglycemia (low blood sugar) symptoms like shakiness, sweating, or confusion, especially in people with diabetes or those taking insulin or other glucose-lowering medications.
Kidney and Liver Concerns: High doses (e.g., >1,000 mcg/day) or long-term use may rarely cause kidney or liver damage, with case reports linking chromium picolinate to kidney dysfunction or elevated liver enzymes. Individuals with pre-existing kidney or liver conditions should avoid high doses.
Mood and Sleep Disturbances: Some users report mood changes, irritability, or insomnia, though these are uncommon and not well-documented.

Important Drug interactions

Antidiabetic medications (metformin, insulin, sulfonylureas) — chromium improves insulin sensitivity; additive glucose-lowering effects; monitor blood sugar closely
NSAIDs (aspirin, ibuprofen) — may increase chromium absorption; monitor chromium levels with long-term NSAID use
Antacids and H2 blockers — reduce chromium absorption; take chromium supplement separately from antacids by 2 hours
Thyroid medications — chromium may interfere with levothyroxine absorption; separate by 3–4 hours

Frequently asked questions about Chromium

How much chromium should I take?

Supplements commonly provide 200 to 1,000 mcg per day, often as chromium picolinate. The adequate intake from diet is only about 25 to 35 mcg, so supplements far exceed baseline needs; most blood-sugar studies use 200 to 1,000 mcg.

What is chromium used for?

Chromium is a trace mineral that supports the action of insulin, so it is studied for healthy blood sugar and carbohydrate metabolism, and sometimes for appetite and cravings. Chromium picolinate is the most common supplemental form.

Does chromium help with blood sugar or weight?

Evidence is mixed. Some studies suggest chromium may modestly support healthy blood sugar, particularly in people with low chromium status, while its effects on weight and cravings are small and inconsistent. View it as supportive, not a primary tool.

Is chromium safe?

Chromium picolinate is generally well tolerated at typical doses. Very high intakes have occasionally been linked to side effects, and it can interact with some medications (including thyroid and diabetes drugs), so check with your doctor if you take those.

What is Chromium?

Chromium is an essential trace mineral that plays a key role in regulating blood sugar by enhancing the effects of insulin, making it important for carbohydrate and fat metabolism. It is naturally found in small amounts in foods such as whole grains, broccoli, green beans, meat, poultry, nuts, and eggs.

What are the signs of Chromium deficiency?

Chromium's status as an essential nutrient is debated, and isolated dietary deficiency has never been definitively documented in healthy people. The few documented cases were patients on long-term TPN who developed insulin resistance reversed by chromium supplementation.

What is the recommended dosage of Chromium?

The clinically studied dose is 25–35 mcg/day (AI); blood sugar: 200–1,000 mcg/day chromium picolinate; insulin resistance studies use 400–1,000 mcg/day Always follow the product label and check with a healthcare provider for personal advice.

Is Chromium safe, and does it have side effects?

For most healthy adults, Chromium is well tolerated at studied doses. Reported effects can include: Gastrointestinal Issues: Common side effects include nausea, stomach irritation, vomiting, or diarrhea, especially at higher doses (e.g., above 1,000 mcg/day) or when taken on an empty stomach. Some users report abdominal pain or bloating. It may also interact with some medications. Chromium is not right for everyone, so check with a healthcare provider first if you are pregnant or breastfeeding, have a medical condition, or take prescription medication.

Does Chromium interact with any medications?

Possible interactions include: Antidiabetic medications (metformin, insulin, sulfonylureas) — chromium improves insulin sensitivity; additive glucose-lowering effects; monitor blood sugar closely NSAIDs (aspirin, ibuprofen) — may increase chromium absorption; monitor chromium levels with long-term NSAID use If you take prescription medication, check with a pharmacist or doctor before using it.

How strong is the scientific evidence for Chromium?

NutraSmarts rates the evidence for Chromium as Moderate (3 out of 5). It is backed by 5 clinical trials and 1 cited reference summarized on this page. A higher rating reflects more, larger, and better-designed human studies.

References(1 citations)

Evidence ratings on NutraSmarts are based on the totality of human clinical research, with emphasis on randomized controlled trials, meta-analyses, and systematic reviews. The references below directly support claims made throughout this page.

  1. Asbaghi O, Fatemeh N, Mahnaz RK, et al. Effects of chromium supplementation on glycemic control in patients with type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials. Pharmacol Res. 2020;161:105098..PubMedUsed to support: Meta-analysis supporting chromium for glycemic control in type 2 diabetes.